Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pyrazolone-derivatives and their use as PDE-4 inhibitors

Pyrazolone-derivatives and their use as PDE-4 inhibitors

US Patent 9340522 · Granted May 17, 2016

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2025
2-phenyl-3,4-dihydropyrrolo[2,1-f] [1,2,4]triazinone derivatives as phosphodiest2025
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2024
2-phenyl-3,4-dihydropyrrolo[2,1 -f] [1,2,4]triazinone derivatives as phosphodies2024
2-phenyl-3,4-dihydropyrrolo[2,1-Ff] [1,2,4]triazinone derivatives as phosphodies2022
Dual mode of action soluble guanylate cyclase activators and phosphodiesterase i2021
Somatostatin receptor subtype 4 (SSTR4) agonists2020
2-phenyl-3,4-dihydropyrrolo[2,1 -F] [1,2,4]triazinone derivatives as phosphodies2020
Somatostatin receptor subtype 4 (SSTR4) agonists2019
Somatostatin receptor subtype 4 (SSTR4) agonists2017
Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors 2017
Combination of HMG-CoA reductase inhibitors with phosphodiesterase 4 inhibitors 2017